![Jan Komtebedde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Komtebedde
Hoofd Techniek/Wetenschap/O&O bij Corvia Medical, Inc.
Actieve functies van Jan Komtebedde
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Corvia Medical, Inc.
![]() Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Jan Komtebedde
Eerdere bekende functies van Jan Komtebedde
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Ancora Heart, Inc.
![]() Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Heartport, Inc.
![]() Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Hoofd Techniek/Wetenschap/O&O | - | - |
UC Davis School of Medicine | Corporate Officer/Principal | - | - |
Evalve, Inc.
![]() Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Verkoop & Marketing | 01-07-2001 | - |
Opleiding van Jan Komtebedde
University of Utrecht | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Nederland | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Evalve, Inc.
![]() Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Heartport, Inc.
![]() Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Corvia Medical, Inc.
![]() Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Health Technology |
Ancora Heart, Inc.
![]() Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Finance |
- Beurs
- Insiders
- Jan Komtebedde
- Ervaring